Tanezumab and Nerve Function In Arthritis Patients

NCT00863772 PHASE3 TERMINATED Results posted

Tanezumab reduces pain of osteoarthritis without affecting how nerve impulses are transmitted in sensory nerves.

Details

Lead sponsor	Pfizer
Phase	PHASE3
Status	TERMINATED
Enrolment	220
Start date	Mon May 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Osteoarthritis

Interventions

• tanezumab
• tanezumab
• Placebo

Countries

United States